Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Profound Medical (PROF) Inventory (2023 - 2025)

Profound Medical has reported Inventory over the past 3 years, most recently at $8.2 million for Q4 2025.

  • Quarterly results put Inventory at $8.2 million for Q4 2025, up 42.01% from a year ago — trailing twelve months through Dec 2025 was $8.2 million (up 42.01% YoY), and the annual figure for FY2025 was $8.2 million, up 42.01%.
  • Inventory for Q4 2025 was $8.2 million at Profound Medical, down from $8.3 million in the prior quarter.
  • Over the last five years, Inventory for PROF hit a ceiling of $8.4 million in Q2 2025 and a floor of $5.8 million in Q4 2024.
  • Median Inventory over the past 3 years was $7.6 million (2023), compared with a mean of $7.4 million.
  • Biggest five-year swings in Inventory: dropped 17.0% in 2024 and later soared 42.01% in 2025.
  • Profound Medical's Inventory stood at $7.0 million in 2023, then fell by 17.0% to $5.8 million in 2024, then soared by 42.01% to $8.2 million in 2025.
  • The last three reported values for Inventory were $8.2 million (Q4 2025), $8.3 million (Q3 2025), and $8.4 million (Q2 2025) per Business Quant data.